Inactive Instrument

News Pharmacielo Ltd Toronto S.E.

Equities

CA00035L1022

Summary

Unlock all the news: Be the first to know and act before the market!

Canadian Investment Regulatory Organization Trading Halt - PCLO	05-08	AQ
PharmaCielo Announces Issuance of Failure to File Cease Trade Order	05-08	NE
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors	04-10	NE
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	04-09	CI
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil	03-26	NE
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo	03-01	NE
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	01-04	CI
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	01-04	NE
PharmaCielo Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
PharmaCielo Announces Q3 2023 Financial Results	11-29	NE
PharmaCielo Raises $3.3 Million Under Non-Brokered Private Placement	23-10-06	MT
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement	23-10-06	NE
PharmaCielo Ltd. announced that it has received CAD 4.78 million in funding	23-10-05	CI
PharmaCielo Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
Pharmacielo Ltd. Appoints Marc Lustig as CEO	23-07-11	CI
Pharmacielo Ltd. Announces Board Changes	23-07-11	CI
PharmaCielo Ltd. announced that it expects to receive CAD 5 million in funding	23-06-28	CI
PharmaCielo Ltd. announced that it has received CAD 12.825 million in funding	23-06-28	CI
PharmaCielo Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-29	CI
PharmaCielo Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pharmacielo Ltd Toronto S.E.

Equities

CA00035L1022

Summary

Filters